Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Sorafenib Versus Observation Following Radical Metastasectomy for Clear-cell Renal Cell Carcinoma: Results from the Phase 2 Randomized Open-label RESORT Study.

Procopio G, Apollonio G, Cognetti F, Miceli R, Milella M, Mosca A, Chiuri VE, Bearz A, Morelli F, Ortega C, Atzori F, Donini M, Ratta R, Raimondi A, Claps M, Martinetti A, Capitanio U, de Braud FG, Cappelletti V, Verzoni E.

Eur Urol Oncol. 2019 Sep 18. pii: S2588-9311(19)30137-3. doi: 10.1016/j.euo.2019.08.011. [Epub ahead of print]

PMID:
31542243
2.

Histological analysis of the anterolateral ligament of the knee.

Sabatini L, Risitano S, Atzori F, Volante M, Aprato A, Indelli PF, Massè A.

J Orthop. 2019 Apr 8;16(5):368-372. doi: 10.1016/j.jor.2019.03.019. eCollection 2019 Sep-Oct.

PMID:
31011250
3.

The effect of a treatment delay on outcome in metastatic renal cell carcinoma.

Iacovelli R, Galli L, De Giorgi U, Porta C, Nolè F, Zucali P, Sabbatini R, Mosca A, Atzori F, Santini D, Facchini G, Fornarini G, Buti S, Massari F, Masini C, Ricotta R, Biasco E, Lolli C, Gri N, Verri E, Miggiano C, Vitale MG, Tortora G.

Urol Oncol. 2019 Aug;37(8):529.e1-529.e7. doi: 10.1016/j.urolonc.2019.03.005. Epub 2019 Mar 29.

PMID:
30935843
4.

Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients.

Cortellini A, Chiari R, Ricciuti B, Metro G, Perrone F, Tiseo M, Bersanelli M, Bordi P, Santini D, Giusti R, Grassadonia A, Di Marino P, Tinari N, De Tursi M, Zoratto F, Veltri E, Malorgio F, Garufi C, Russano M, Anesi C, Zeppola T, Filetti M, Marchetti P, Berardi R, Rinaldi S, Tudini M, Silva RR, Pireddu A, Atzori F, Iacono D, Migliorino MR, Porzio G, Cannita K, Ficorella C, Buti S.

Clin Lung Cancer. 2019 Jul;20(4):237-247.e1. doi: 10.1016/j.cllc.2019.02.006. Epub 2019 Feb 21.

PMID:
30885550
5.

A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable.

Cortellini A, Bersanelli M, Buti S, Cannita K, Santini D, Perrone F, Giusti R, Tiseo M, Michiara M, Di Marino P, Tinari N, De Tursi M, Zoratto F, Veltri E, Marconcini R, Malorgio F, Russano M, Anesi C, Zeppola T, Filetti M, Marchetti P, Botticelli A, Antonini Cappellini GC, De Galitiis F, Vitale MG, Rastelli F, Pergolesi F, Berardi R, Rinaldi S, Tudini M, Silva RR, Pireddu A, Atzori F, Chiari R, Ricciuti B, De Giglio A, Iacono D, Gelibter A, Occhipinti MA, Parisi A, Porzio G, Fargnoli MC, Ascierto PA, Ficorella C, Natoli C.

J Immunother Cancer. 2019 Feb 27;7(1):57. doi: 10.1186/s40425-019-0527-y.

6.

Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study.

Cortellini A, Buti S, Santini D, Perrone F, Giusti R, Tiseo M, Bersanelli M, Michiara M, Grassadonia A, Brocco D, Tinari N, De Tursi M, Zoratto F, Veltri E, Marconcini R, Malorgio F, Garufi C, Russano M, Anesi C, Zeppola T, Filetti M, Marchetti P, Botticelli A, Antonini Cappellini GC, De Galitiis F, Vitale MG, Sabbatini R, Bracarda S, Berardi R, Rinaldi S, Tudini M, Silva RR, Pireddu A, Atzori F, Chiari R, Ricciuti B, Iacono D, Migliorino MR, Rossi A, Porzio G, Cannita K, Ciciarelli V, Fargnoli MC, Ascierto PA, Ficorella C.

Oncologist. 2019 Jun;24(6):e327-e337. doi: 10.1634/theoncologist.2018-0618. Epub 2019 Feb 22.

PMID:
30796151
7.

Correction 2: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study.

Cazzaniga M, Verusio C, Ciccarese M, Fumagalli A, Sartori D, Valerio MR, Airoldi M, Moretti G, Ficorella C, Arcangeli V, Diodati L, Zambelli A, Febbraro A, Generali D, Pistelli M, Garrone O, Musolino A, Vici P, Maur M, Mentuccia L, La Verde N, Bianchi G, Artale S, Blasi L, Piezzo M, Atzori F, Turletti A, Benedetto C, Cursano MC, Fabi A, Gebbia V, Schirone A, Palumbo R, Ferzi A, Frassoldati A, Scavelli C, Clivio L, Torri V.

Oncotarget. 2018 Nov 30;9(94):36720-36721. doi: 10.18632/oncotarget.26431. eCollection 2018 Nov 30.

8.

Safety and Efficacy of Pazopanib in First-Line Metastatic Renal-Cell Carcinoma With or Without Renal Failure: CORE-URO-01 Study.

Masini C, Vitale MG, Maruzzo M, Procopio G, de Giorgi U, Buti S, Rossetti S, Iacovelli R, Atzori F, Cosmai L, Vignani F, Prati G, Scagliarini S, Guida A, Berselli A, Pinto C.

Clin Genitourin Cancer. 2019 Feb;17(1):e150-e155. doi: 10.1016/j.clgc.2018.10.001. Epub 2018 Oct 10.

PMID:
30396828
9.

Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study.

Cazzaniga M, Verusio C, Ciccarese M, Fumagalli A, Sartori D, Valerio MR, Airoldi M, Moretti G, Ficorella C, Arcangeli V, Diodati L, Zambelli A, Febbraro A, Generali D, Pistelli M, Garrone O, Musolino A, Vici P, Maur M, Mentuccia L, La Verde N, Bianchi G, Artale S, Blasi L, Piezzo M, Atzori F, Turletti A, Benedetto C, Cursano MC, Fabi A, Gebbia V, Schirone A, Palumbo R, Ferzi A, Frassoldati A, Scavelli C, Clivio L, Torri On Behalf Of The Eva Study Group V.

Oncotarget. 2018 Oct 2;9(77):34639-34640. doi: 10.18632/oncotarget.26213. eCollection 2018 Oct 2.

10.

INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study.

Bersanelli M, Giannarelli D, Castrignanò P, Fornarini G, Panni S, Mazzoni F, Tiseo M, Rossetti S, Gambale E, Rossi E, Papa A, Cortellini A, Lolli C, Ratta R, Michiara M, Milella M, De Luca E, Sorarù M, Mucciarini C, Atzori F, Banna GL, La Torre L, Vitale MG, Massari F, Rebuzzi SE, Facchini G, Schinzari G, Tomao S, Bui S, Vaccaro V, Procopio G, De Giorgi U, Santoni M, Ficorella C, Sabbatini R, Maestri A, Natoli C, De Tursi M, Di Maio M, Rapacchi E, Pireddu A, Sava T, Lipari H, Comito F, Verzoni E, Leonardi F, Buti S.

Immunotherapy. 2018 Oct;10(14):1229-1239. doi: 10.2217/imt-2018-0080.

PMID:
30326787
11.

Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study.

Cazzaniga M, Verusio C, Ciccarese M, Fumagalli A, Sartori D, Valerio MR, Ancona C, Airoldi M, Moretti G, Ficorella C, Arcangeli V, Diodati L, Zambelli A, Febbraro A, Generali D, Pistelli M, Garrone O, Musolino A, Vici P, Maur M, Mentuccia L, La Verde N, Bianchi G, Artale S, Blasi L, Piezzo M, Atzori F, Turletti A, Benedetto C, Cursano MC, Fabi A, Gebbia V, Schirone A, Palumbo R, Ferzi A, Frassoldati A, Scavelli C, Clivio L, Torri On Behalf Of The Eva Study Group V.

Oncotarget. 2018 Aug 7;9(61):31877-31887. doi: 10.18632/oncotarget.25874. eCollection 2018 Aug 7. Erratum in: Oncotarget. 2018 Oct 2;9(77):34639-34640. Valerio, Maria Rosario [added]. Oncotarget. 2018 Nov 30;9(94):36720-36721.

12.

Benthic mucilage blooms threaten coralligenous reefs.

Piazzi L, Atzori F, Cadoni N, Cinti MF, Frau F, Ceccherelli G.

Mar Environ Res. 2018 Sep;140:145-151. doi: 10.1016/j.marenvres.2018.06.011. Epub 2018 Jun 14.

PMID:
29921450
13.

The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma.

Iacovelli R, Cossu Rocca M, Galli L, Sabbatini R, De Giorgi U, Santini D, Facchini G, Mosca A, Atzori F, Zucali P, Fornarini G, Massari F, Buti S, Ricotta R, Masini C, Toscani I, Biasco E, Guida A, Lolli C, De Lisi D, Rossetti S, Terrone C, Scartozzi M, Miggiano C, Pastorino A, Bersanelli M, Carlo-Stella G, Pinto C, Nobili E, Nolè F, Tortora G, Porta C.

Anticancer Drugs. 2018 Aug;29(7):705-709. doi: 10.1097/CAD.0000000000000632.

PMID:
29846246
14.

Is It Possible to Improve Prognostic Classification in Patients Affected by Metastatic Renal Cell Carcinoma With an Intermediate or Poor Prognosis?

Iacovelli R, De Giorgi U, Galli L, Zucali P, Nolè F, Sabbatini R, Fraccon AP, Basso U, Mosca A, Atzori F, Santini D, Facchini G, Fornarini G, Pasini F, Masini C, Massari F, Buti S, Sava T, Sacco C, Ricotta R, Sperduti I, Tortora G, Porta C.

Clin Genitourin Cancer. 2018 Oct;16(5):355-359.e1. doi: 10.1016/j.clgc.2018.04.007. Epub 2018 May 7.

PMID:
29803346
15.

ALEX index enables detection of alien macroalgae invasions across habitats within a marine protected area.

Piazzi L, Gennaro P, Atzori F, Cadoni N, Cinti MF, Frau F, Ceccherelli G.

Mar Pollut Bull. 2018 Mar;128:318-323. doi: 10.1016/j.marpolbul.2018.01.034. Epub 2018 Feb 6.

PMID:
29571378
16.

Family history of cancer as surrogate predictor for immunotherapy with anti-PD1/PD-L1 agents: preliminary report of the FAMI-L1 study.

Cortellini A, Bersanelli M, Buti S, Gambale E, Atzori F, Zoratto F, Parisi A, Brocco D, Pireddu A, Cannita K, Iacono D, Migliorino MR, Gamucci T, De Tursi M, Sidoni T, Tiseo M, Michiara M, Papa A, Angius G, Tomao S, Fargnoli MC, Natoli C, Ficorella C.

Immunotherapy. 2018 Jun;10(8):643-655. doi: 10.2217/imt-2017-0167. Epub 2018 Mar 22.

17.

Static antibiotic spacers augmented by calcium sulphate impregnated beads in revision TKA: Surgical technique and review of literature.

Risitano S, Sabatini L, Atzori F, Massè A, Indelli PF.

J Orthop. 2018 Feb 21;15(2):313-318. doi: 10.1016/j.jor.2018.02.008. eCollection 2018 Jun. Review.

18.

Medial Pivot in Total Knee Arthroplasty: Literature Review and Our First Experience.

Sabatini L, Risitano S, Parisi G, Tosto F, Indelli PF, Atzori F, Massè A.

Clin Med Insights Arthritis Musculoskelet Disord. 2018 Jan 4;11:1179544117751431. doi: 10.1177/1179544117751431. eCollection 2018. Review.

19.

Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients.

Urru SAM, Gallus S, Bosetti C, Moi T, Medda R, Sollai E, Murgia A, Sanges F, Pira G, Manca A, Palmas D, Floris M, Asunis AM, Atzori F, Carru C, D'Incalci M, Ghiani M, Marras V, Onnis D, Santona MC, Sarobba G, Valle E, Canu L, Cossu S, Bulfone A, Rocca PC, De Miglio MR, Orrù S.

BMC Cancer. 2018 Jan 8;18(1):56. doi: 10.1186/s12885-017-3969-y.

20.

Biochemical stress evaluation after medial parapatellar and subvastus approach in total knee replacement.

Sabatini L, Nicolaci G, Atzori F, Oliva A, Aprato A, Terzolo M, Masse' A.

Musculoskelet Surg. 2018 Aug;102(2):185-190. doi: 10.1007/s12306-017-0521-9. Epub 2017 Nov 20.

PMID:
29159505
21.

Amount, composition, and spatial distribution of floating macro litter along fixed trans-border transects in the Mediterranean basin.

Arcangeli A, Campana I, Angeletti D, Atzori F, Azzolin M, Carosso L, Di Miccoli V, Giacoletti A, Gregorietti M, Luperini C, Paraboschi M, Pellegrino G, Ramazio M, Sarà G, Crosti R.

Mar Pollut Bull. 2018 Apr;129(2):545-554. doi: 10.1016/j.marpolbul.2017.10.028. Epub 2017 Oct 16.

PMID:
29042107
22.

Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2-) advanced breast cancer patients: New insights beyond clinical trials. The EVA study.

Cazzaniga ME, Airoldi M, Arcangeli V, Artale S, Atzori F, Ballerio A, Bianchi GV, Blasi L, Campidoglio S, Ciccarese M, Cursano MC, Piezzo M, Fabi A, Ferrari L, Ferzi A, Ficorella C, Frassoldati A, Fumagalli A, Garrone O, Gebbia V, Generali D, La Verde N, Maur M, Michelotti A, Moretti G, Musolino A, Palumbo R, Pistelli M, Porpiglia M, Sartori D, Scavelli C, Schirone A, Turletti A, Valerio MR, Vici P, Zambelli A, Clivio L, Torri V; on behalf of; EVA Study Group.

Breast. 2017 Oct;35:115-121. doi: 10.1016/j.breast.2017.06.043. Epub 2017 Jul 13.

23.

Condylar constrained system in primary total knee replacement: our experience and literature review.

Sabatini L, Risitano S, Rissolio L, Bonani A, Atzori F, Massè A.

Ann Transl Med. 2017 Mar;5(6):135. doi: 10.21037/atm.2017.03.29.

24.

Patellofemoral Joint Arthroplasty: Our Experience in Isolated Patellofemoral and Bicompartmental Arthritic Knees.

Sabatini L, Schirò M, Atzori F, Ferrero G, Massè A.

Clin Med Insights Arthritis Musculoskelet Disord. 2016 Nov 15;9:189-193. eCollection 2016.

25.

Hypothyroidism and Thyroid Autoimmunity as a Prognostic Biomarker of Better Response in Metastatic Cancer Long-Term Survivors Treated with Sunitinib.

Pani F, Atzori F, Baghino G, Boi F, Ionta MT, Tanca L, Scartozzi M, Mariotti S.

Thyroid. 2016 Sep;26(9):1336-7. doi: 10.1089/thy.2016.0159. Epub 2016 Jul 11. No abstract available.

PMID:
27267354
26.

Medial pivot knee in primary total knee arthroplasty.

Atzori F, Salama W, Sabatini L, Mousa S, Khalefa A.

Ann Transl Med. 2016 Jan;4(1):6. doi: 10.3978/j.issn.2305-5839.2015.12.20. Review.

27.

Bicompartmental knee arthroplasty.

Sabatini L, Giachino M, Risitano S, Atzori F.

Ann Transl Med. 2016 Jan;4(1):5. doi: 10.3978/j.issn.2305-5839.2015.12.24. Review.

28.

Thyroid Dysfunction in Patients with Metastatic Carcinoma Treated with Sunitinib: Is Thyroid Autoimmunity Involved?

Pani F, Atzori F, Baghino G, Boi F, Tanca L, Ionta MT, Mariotti S.

Thyroid. 2015 Nov;25(11):1255-61. doi: 10.1089/thy.2015.0170. Epub 2015 Oct 14.

PMID:
26414109
29.

Oral chemotherapy and patient perspective in solid tumors: a national survey by the Italian association of medical oncology.

Aurilio G, Gori S, Nolè F, Pruneri G, Coati F, Torri V, Lunardi G, Atzori F, La Verde N, Banna GL, Rossi A, Del Mastro L, Di Fabio F, Marcon I, Gebbia V, Loupakis F, Orlando L, Ciuffreda L, Amadio P, Luppi G, Redana S, Filippelli G, Gentile A, Collovà E.

Tumori. 2016 Jan-Feb;102(1):108-13. doi: 10.5301/tj.5000383. Epub 2015 Jul 2.

PMID:
26166216
30.

Topical intra-articular and intravenous tranexamic acid to reduce blood loss in total knee arthroplasty.

Sabatini L, Atzori F.

Ann Transl Med. 2015 May;3(Suppl 1):S18. doi: 10.3978/j.issn.2305-5839.2015.02.25. No abstract available.

31.

Genome-wide association study of susceptibility loci for breast cancer in Sardinian population.

Palomba G, Loi A, Porcu E, Cossu A, Zara I, Budroni M, Dei M, Lai S, Mulas A, Olmeo N, Ionta MT, Atzori F, Cuccuru G, Pitzalis M, Zoledziewska M, Olla N, Lovicu M, Pisano M, Abecasis GR, Uda M, Tanda F, Michailidou K, Easton DF, Chanock SJ, Hoover RN, Hunter DJ, Schlessinger D, Sanna S, Crisponi L, Palmieri G.

BMC Cancer. 2015 May 10;15:383. doi: 10.1186/s12885-015-1392-9.

32.

Erratum to: Evaluation of anterior knee pain in a PS total knee arthroplasty: the role of patella-friendly femoral component and patellar size.

Atzori F, Sabatini L, Deledda D, Schirò M, Lo Baido R, Massè A.

Musculoskelet Surg. 2015 Apr;99(1):85. doi: 10.1007/s12306-015-0349-0. No abstract available.

PMID:
25795028
33.

Evaluation of anterior knee pain in a PS total knee arthroplasty: the role of patella-friendly femoral component and patellar size.

Atzori F, Sabatini L, Deledda D, Schirò M, Lo Baido R, Massè A.

Musculoskelet Surg. 2015 Apr;99(1):75-83. doi: 10.1007/s12306-015-0347-2. Epub 2015 Feb 12. Erratum in: Musculoskelet Surg. 2015 Apr;99(1):85. Baido, RL [corrected to Lo Baido, R].

PMID:
25672918
34.

Prognostic factors in patients receiving third line targeted therapy for metastatic renal cell carcinoma.

Iacovelli R, Farcomeni A, Sternberg CN, Cartenì G, Milella M, Santoni M, Cerbone L, Di Lorenzo G, Verzoni E, Ortega C, Sabbatini R, Ricotta R, Messina C, Lorusso V, Atzori F, De Vincenzo F, Sacco C, Boccardo F, Valduga F, Massari F, Baldazzi V, Cinieri S, Mosca A, Maria Ruggeri E, Berruti A, Procopio G.

J Urol. 2015 Jun;193(6):1905-10. doi: 10.1016/j.juro.2014.11.092. Epub 2014 Nov 26.

PMID:
25433306
35.

Efficacy of trastuzumab in unselected patients with HER2-positive metastatic breast cancer: a retrospective analysis.

Collovà E, Ferzi A, Scandurra G, Aurilio G, Torri V, Porcu L, Sanò MV, Taibi E, Foglietta J, Generali D, Andreis D, Dazzani MC, Bramati A, Marcon I, Atzori F, Cinieri S, Tondulli L, Grasso D, Nolè F, Petrella MC, Gori S, La Verde N.

Tumori. 2014 Jul-Aug;100(4):426-31. doi: 10.1700/1636.17902.

PMID:
25296592
36.

Can we predict femoral head vitality during surgical hip dislocation?

Aprato A, Bonani A, Giachino M, Favuto M, Atzori F, Masse A.

J Hip Preserv Surg. 2014 Oct 21;1(2):77-81. doi: 10.1093/jhps/hnu010. eCollection 2014 Oct.

37.

ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy.

Palomba G, Atzori F, Budroni M, Ombra M, Cossu A, Sini M, Pusceddu V, Massidda B, Frau B, Notari F, Ionta M, Palmieri G.

J Transl Med. 2014 Sep 25;12:272. doi: 10.1186/s12967-014-0272-4.

38.

Intravenous use of tranexamic acid reduces postoperative blood loss in total knee arthroplasty.

Sabatini L, Atzori F, Revello S, Scotti L, Debiasi F, Massè A.

Arch Orthop Trauma Surg. 2014 Nov;134(11):1609-14. doi: 10.1007/s00402-014-2081-x. Epub 2014 Sep 3.

PMID:
25179896
39.

Sunitinib, pazopanib or sorafenib for the treatment of patients with late relapsing metastatic renal cell carcinoma.

Santoni M, Conti A, Porta C, Procopio G, Sternberg CN, Basso U, De Giorgi U, Bracarda S, Rizzo M, Ortega C, Massari F, Iacovelli R, Derosa L, Masini C, Milella M, Di Lorenzo G, Atzori F, Pagano M, Buti S, De Vivo R, Mosca A, Rossi M, Paglino C, Verzoni E, Cerbone L, Muzzonigro G, Falconi M, Montironi R, Burattini L, Santini D, Cascinu S.

J Urol. 2015 Jan;193(1):41-7. doi: 10.1016/j.juro.2014.07.011. Epub 2014 Jul 18.

PMID:
25046616
40.

Triple-negative breast cancer frequency and type of BRCA mutation: Clues from Sardinia.

Palomba G, Budroni M, Olmeo N, Atzori F, Ionta MT, Pisano M, Tanda F, Cossu A, Palmieri G.

Oncol Lett. 2014 Apr;7(4):948-952. Epub 2014 Jan 28.

41.

CONTRIBUTION OF A GENERALIST PREDATOR AND A LARVAL PARASITOID FOR THE CONTROL OF TUTA ABSOLUTA (MEYRICK) ON GREENHOUSE TOMATOES.

Nannini M, Atzori F, Murgia G, Pisci R, Sanna F, Sau S.

Commun Agric Appl Biol Sci. 2014;79(2):205. No abstract available.

PMID:
26084098
42.

NATIVE LARVAL PARASITOIDS ASSOCIATED WITH TUTA ABSOLUTA (MEYRICK) IN GREENHOUSE TOMATO CROPS OF SOUTHERN SARDINIA.

Nannini M, Atzori F, Pisci R, Sanna F.

Commun Agric Appl Biol Sci. 2014;79(2):199-203.

PMID:
26084097
43.

Male breast cancer: clinical features and multimodal treatment in a retrospective survey analysis at Italian centers.

La Verde N, Collovà E, Lonardi S, Generali D, Moretti A, Atzori F, Cazzaniga M, Saggia C, Tondulli L, Marcon I, Gentile AL, Rossello R, Martelli O, Aglione S, Farina G, Cinquini M, Garassino M.

Tumori. 2013 Sep-Oct;99(5):596-600. doi: 10.1700/1377.15308.

PMID:
24362863
44.

Treatment of irradiated expanders: protective lipofilling allows immediate prosthetic breast reconstruction in the setting of postoperative radiotherapy.

Ribuffo D, Atzeni M, Guerra M, Bucher S, Politi C, Deidda M, Atzori F, Dessi M, Madeddu C, Lay G.

Aesthetic Plast Surg. 2013 Dec;37(6):1146-52. doi: 10.1007/s00266-013-0221-2. Epub 2013 Oct 10.

PMID:
24114295
45.

Clinical outcomes in patients receiving three lines of targeted therapy for metastatic renal cell carcinoma: results from a large patient cohort.

Iacovelli R, Cartenì G, Sternberg CN, Milella M, Santoni M, Di Lorenzo G, Ortega C, Sabbatini R, Ricotta R, Messina C, Lorusso V, Atzori F, De Vincenzo F, Sacco C, Boccardo F, Valduga F, Massari F, Baldazzi V, Cinieri S, Mosca A, Ruggeri EM, Berruti A, Cerbone L, Procopio G.

Eur J Cancer. 2013 Jun;49(9):2134-42. doi: 10.1016/j.ejca.2013.02.032. Epub 2013 Mar 18.

PMID:
23518211
46.

Dasatinib plus capecitabine for advanced breast cancer: safety and efficacy in phase I study CA180004.

Somlo G, Atzori F, Strauss LC, Geese WJ, Specht JM, Gradishar WJ, Rybicki A, Sy O, Vahdat LT, Cortes J.

Clin Cancer Res. 2013 Apr 1;19(7):1884-93. doi: 10.1158/1078-0432.CCR-12-0652. Epub 2013 Feb 12.

47.

Magnetic resonance arthrography for femoroacetabular impingement surgery: is it reliable?

Aprato A, Massè A, Faletti C, Valente A, Atzori F, Stratta M, Jayasekera N.

J Orthop Traumatol. 2013 Sep;14(3):201-6. doi: 10.1007/s10195-013-0227-1. Epub 2013 Feb 9.

48.

Jejunal obstruction caused by metastasis from an undiagnosed breast cancer: a case report.

Calò PG, Fanni D, Ionta MT, Medas F, Faa G, Atzori F.

Tumori. 2012 May-Jun;98(3):89e-91e. doi: 10.1700/1125.12419.

PMID:
22825527
49.

PCBs contamination does not alter aerobic metabolism and tolerance to hypoxia of juvenile sole (Solea solea L. 1758).

Cannas M, Atzori F, Rupsard F, Bustamante P, Loizeau V, Lefrançois C.

Aquat Toxicol. 2013 Feb;127:54-60. doi: 10.1016/j.aquatox.2012.04.017. Epub 2012 May 11.

PMID:
22682372
50.

Haplotype affinities resolve a major component of goat (Capra hircus) MtDNA D-loop diversity and reveal specific features of the Sardinian stock.

Piras D, Doro MG, Casu G, Melis PM, Vaccargiu S, Piras I, Parracciani D, Stradoni R, Frongia B, Lai G, Sale S, Cattari W, Piras R, Querci O, Demuro P, Cui S, Atzori F, Mancosu M, Marchiori F, Cammelli R, Spiga A, Loddo PP, Pili G, Boi R, Argiolas G, Mereu P, Leoni GG, Naitana S, Pirastu M, Novelletto A.

PLoS One. 2012;7(2):e30785. doi: 10.1371/journal.pone.0030785. Epub 2012 Feb 17.

Supplemental Content

Loading ...
Support Center